It took weeks of intense, protracted negotiation, but just days before Christmas, House and Senate leaders finally clinched an agreement to send a massive end-of-year legislative package, including $900 billion in coronavirus relief, a $1.4 trillion spending bill to fund all federal agencies until the end of September 2021, and extension of the Special Diabetes...
As 2020 winds down, Endocrine News is taking a quick jaunt down memory lane to focus on the many accomplishments the Endocrine Society had over the course of the last 12 months. Despite various obstacles and upended plans, 2020 turned out to be a remarkable year for progress and successful new endeavors. We were somewhere...
The Endocrine Society is an advocate for transgender patients and ensuring their access to gender-affirming, evidence-based healthcare. During the Fall, the Society’s Transgender Special Interest Group and members of the Pediatric Endocrine Society formed a working group to update Society documents and develop new material on care for transgender individuals to be used in advocacy...
In the wake of Joe Biden’s win of the 2020 presidential election, the Endocrine Society has looked at what a change in presidential administration could mean for its policy agenda and provided a few predictions: Immediate Priorities The “lame duck” period and first 100 days of a Biden Administration will likely be dominated by urgent efforts...
Endocrine Society has been an active leader on Capitol Hill advocating for diabetes prevention, coverage, and research programs. Here are some highlights of our recent activities: On October 5, the Society hosted a virtual congressional briefing focused on how the National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK) addresses racial and ethnic disparities. The...
In a landmark ruling, the Supreme Court of the United States found that gay and transgender individuals cannot be discriminated against in the workplace on the basis of sex. The 6-3 decision stated that Title VII of the Civil Rights Act of 1964, which prohibits discrimination “because of sex,” includes gay and transgender employees. The...
As the pandemic took hold in the U.S. and communities implemented strict social distancing measures, including stay-at-home orders, the Endocrine Society pivoted its advocacy approach to Congress and launched a strategic “virtual” Hill Day to advocate our recommendations for relief legislation. Originally, the Society had planned a Hill Day for April 20 to bring members...
High drug prices have been a focus of Congress and the Trump Administration for the past year, with insulin becoming the prime example of the negative impact increasing drug prices are having on patients. The Endocrine Society has made addressing the high cost of insulin a priority for the past three years. We have urged...
In the wake of Joe Biden’s win of the 2020 presidential election, the Endocrine Society has looked at what a change in presidential administration could mean for its policy agenda and provided a few predictions: Immediate Priorities The “lame duck” period and first 100 days of a Biden Administration will likely be dominated by urgent efforts...
